Literature DB >> 9203732

The biologic principles of poliovirus eradication.

W R Dowdle1, M E Birmingham.   

Abstract

The biologic principles for the global eradication of poliomyelitis are as follows: Poliovirus causes acute, nonpersistent infections, virus is transmitted by infectious humans or their waste, survival of virus in the environment is finite, humans are the only reservoir, and immunization with polio vaccine interrupts virus transmission. These principles appear to be sound. The potential for prolonged virus excretion by immunocompromised patients requires further definition, although there is no epidemiologic evidence of a threat to eradication. Survival of poliovirus in the environment is highly variable, but viral inactivation is usually complete within months. Higher primates may be infected with poliovirus, but they are unlikely reservoirs in nature. The only poliovirus reservoir remaining after eradication will be laboratory stocks. Serious attention must be given to reducing this potential source of infection. Polio eradication through immunization is evidenced by the documented absence of poliomyelitis in an increasing number of countries and the progressive disappearance of poliovirus genotypes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203732      PMCID: PMC7110371          DOI: 10.1093/infdis/175.supplement_1.s286

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Expression of an antigenic adenovirus epitope in a group B coxsackievirus.

Authors:  K Höfling; S Tracy; N Chapman; K S Kim; J Smith Leser
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

3.  OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.

Authors:  Alexandre Manirakiza; Emmanuella Picard; Richard Ngbale; Didier Menard; Ionela Gouandjika-Vasilache
Journal:  BMC Res Notes       Date:  2010-05-18

4.  Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia.

Authors:  Hinda Triki; Mohamed Ridha Barbouche; Olfa Bahri; Mohamed Bejaoui; Koussay Dellagi
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Prolonged replication of a type 1 vaccine-derived poliovirus in an immunodeficient patient.

Authors:  O M Kew; R W Sutter; B K Nottay; M J McDonough; D R Prevots; L Quick; M A Pallansch
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

Review 6.  Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Authors:  Radboud J Duintjer Tebbens; Marita Zimmermann; Mark A Pallansch; Kimberly M Thompson
Journal:  Food Environ Virol       Date:  2017-07-07       Impact factor: 2.778

7.  Enteroviral infection in Greek AIDS patients.

Authors:  Dimitrios Papaventsis; Panayotis Markoulatos; Nikolaos Mangafas; Marios Lazanas; Stamatina Levidiotou-Stefanou
Journal:  Mol Diagn       Date:  2004

8.  Poliovirus containment risks and their management.

Authors:  Radboud J Duintjer Tebbens; Dominika A Kalkowsa; Kimberly M Thompson
Journal:  Future Virol       Date:  2018-08-10       Impact factor: 1.831

9.  An evaluation of the sensitivity of acute flaccid paralysis surveillance for poliovirus infection in Australia.

Authors:  Rochelle E Watkins; P Anthony J Martin; Heath Kelly; Ben Madin; Charles Watson
Journal:  BMC Infect Dis       Date:  2009-09-30       Impact factor: 3.090

10.  First Detection of an Enterovirus C99 in a Captive Chimpanzee with Acute Flaccid Paralysis, from the Tchimpounga Chimpanzee Rehabilitation Center, Republic of Congo.

Authors:  Illich Manfred Mombo; Nicolas Berthet; Alexander N Lukashev; Tobias Bleicker; Sebastian Brünink; Lucas Léger; Rebeca Atencia; Debby Cox; Christiane Bouchier; Patrick Durand; Céline Arnathau; Lionel Brazier; Joseph N Fair; Bradley S Schneider; Jan Felix Drexler; Franck Prugnolle; Christian Drosten; François Renaud; Eric M Leroy; Virginie Rougeron
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.